Related Experiment Video
Updated: May 17, 2026
07:09
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Treatment for chronic heart failure in the elderly: current practice and problems
Pasquale Abete1, Gianluca Testa, David Della-Morte
1Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Cattedra di Geriatria, Università degli Studi di Napoli Federico II, 80131 Naples, Italy. p.abete@unina.it
Heart Failure Reviews
|November 6, 2012
Summary
Managing chronic heart failure (CHF) in elderly patients presents unique challenges. Evidence-based medicine often falls short, necessitating tailored approaches considering comorbidities and adherence for effective geriatric CHF management.
Area of Science:
- Geriatric Medicine
- Cardiology
- Clinical Pharmacology
Background:
- Evidence-based medicine for chronic heart failure (CHF) often lacks direct applicability to elderly patients.
- Geriatric CHF management is complicated by precipitating factors, non-cardiac comorbidities, and underutilization of first-choice medications.
- Poor therapeutic adherence, particularly in patients with cognitive or depressive disorders, significantly impacts CHF management in the elderly.
Purpose of the Study:
- To review the current challenges and considerations in the clinical management of chronic heart failure in elderly patients.
- To highlight the limitations of standard evidence-based medicine in geriatric populations and explore alternative strategies.
- To emphasize the importance of a multidimensional approach, including self-care, caregiver support, and telemedicine, for optimizing CHF treatment in older adults.
Main Methods:
- Literature review and synthesis of current evidence on chronic heart failure management in geriatric patients.
- Analysis of factors influencing treatment efficacy, including comorbidities, drug adherence, and age-specific considerations.
- Exploration of emerging therapies and supportive care strategies relevant to elderly CHF patients.
Main Results:
- Standard CHF treatments are not always transferable to elderly patients due to comorbidities and adherence issues.
- Key medications like ACE inhibitors and beta-blockers remain underused, and specific treatments for diastolic dysfunction are lacking.
- While electrical therapy, exercise, stem cells, and new devices show promise, their definitive role in elderly CHF is still under investigation. Palliative care and telemedicine are crucial for end-stage disease and follow-up.
Conclusions:
- Effective management of CHF in the elderly requires addressing comorbidities, improving adherence, and adapting therapies to individual needs.
- A multidimensional team approach, incorporating self-care, caregiver training, and telemedicine, is critical for successful outcomes.
- Future research should focus on developing age-specific treatments and validating novel therapeutic and monitoring strategies for geriatric CHF patients.
Related Concept Videos
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...